• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NCAM、p53和细胞周期蛋白D1在切除的非小细胞肺癌中的预后价值。

The prognostic value of NCAM, p53 and cyclin D1 in resected non-small cell lung cancer.

作者信息

Kwa H B, Michalides R J, Dijkman J H, Mooi W J

机构信息

Department of Pulmonology C-3-P, University Hospital Leiden, The Netherlands.

出版信息

Lung Cancer. 1996 Jun;14(2-3):207-17. doi: 10.1016/0169-5002(96)00547-8.

DOI:10.1016/0169-5002(96)00547-8
PMID:8794404
Abstract

Expression of the neural cell adhesion molecule, NCAM, in frozen sections has been associated with decreased postoperative survival in non-small cell lung carcinoma. Of the various isoforms of NCAM described, the highly sialylated isoform plays a role in the migration of embryonal cells from the neural crest and is expressed by highly malignant tumours such as small cell lung carcinomas. We investigated the clinical significance of expression of this NCAM isoform as a prognostic factor in a series of 96 non-small cell lung carcinomas resected with curative intent. We also evaluated the effect of microwave pre-treatment of formalin-fixed, paraffin-embedded sections on the NCAM immunostaining and related the outcome to the postoperative clinical course of disease. In addition, in an attempt to extend our search for possible molecular markers of unfavourable prognosis in lung cancer, we evaluated increased immunostaining for p53 and cyclin D1 in the same series. We did not find a significant relation between expression of NCAM or its highly sialylated isoform and the length of postoperative survival. The numbers of positive cases (9 and 14, respectively) were relatively low. Increased p53 and cyclin D1 immunostaining (50 and 55 of the 96 tumours) failed to show a significant relation with postoperative survival. In our material, tumour stage was the only significant prognostic factor.

摘要

神经细胞黏附分子(NCAM)在冰冻切片中的表达与非小细胞肺癌患者术后生存率降低有关。在已描述的NCAM的各种亚型中,高度唾液酸化的亚型在神经嵴胚胎细胞迁移中起作用,并在诸如小细胞肺癌等高度恶性肿瘤中表达。我们研究了这种NCAM亚型的表达作为预后因素在一系列96例根治性切除的非小细胞肺癌中的临床意义。我们还评估了对福尔马林固定、石蜡包埋切片进行微波预处理对NCAM免疫染色的影响,并将结果与疾病的术后临床病程相关联。此外,为了扩大我们对肺癌不良预后可能分子标志物的研究,我们在同一组病例中评估了p53和细胞周期蛋白D1免疫染色增强的情况。我们未发现NCAM或其高度唾液酸化亚型的表达与术后生存时间之间存在显著关联。阳性病例数(分别为9例和14例)相对较少。p53和细胞周期蛋白D1免疫染色增强(96例肿瘤中有50例和55例)与术后生存情况未显示出显著关联。在我们的研究材料中,肿瘤分期是唯一显著的预后因素。

相似文献

1
The prognostic value of NCAM, p53 and cyclin D1 in resected non-small cell lung cancer.NCAM、p53和细胞周期蛋白D1在切除的非小细胞肺癌中的预后价值。
Lung Cancer. 1996 Jun;14(2-3):207-17. doi: 10.1016/0169-5002(96)00547-8.
2
Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients.肺癌患者手术切缘上皮中CCND1和RB1的异常表达。
Br J Cancer. 1997;75(12):1761-8. doi: 10.1038/bjc.1997.300.
3
Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapy.辅助治疗的淋巴结阳性乳腺癌患者中细胞周期蛋白D1表达的临床意义。
Ann Oncol. 1996 Sep;7(7):695-703. doi: 10.1093/oxfordjournals.annonc.a010718.
4
A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer.一项关于248例可手术乳腺癌患者中细胞周期蛋白D1和p53过表达的临床病理研究。
Br J Cancer. 1996 Mar;73(6):728-34. doi: 10.1038/bjc.1996.128.
5
Biological prognostic factors for early stage completely resected non-small cell lung cancer.早期完全切除的非小细胞肺癌的生物学预后因素
J Surg Oncol. 2000 May;74(1):53-60. doi: 10.1002/1096-9098(200005)74:1<53::aid-jso13>3.0.co;2-d.
6
Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer.p53和ras p21表达在非小细胞肺癌中的预后意义
Cancer. 1995 Dec 15;76(12):2457-63. doi: 10.1002/1097-0142(19951215)76:12<2457::aid-cncr2820761209>3.0.co;2-x.
7
Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.在一组47例可手术切除的头颈部鳞状细胞癌中,细胞周期蛋白D1的过表达与复发相关。
Cancer Res. 1995 Mar 1;55(5):975-8.
8
Cyclin D1 expression in non-small-cell lung cancers: its association with altered p53 expression, cell proliferation and clinical outcome.非小细胞肺癌中细胞周期蛋白D1的表达:其与p53表达改变、细胞增殖及临床结局的关联
Br J Cancer. 1999 Jun;80(8):1289-95. doi: 10.1038/sj.bjc.6990500.
9
Expression of cyclin D1, Ki-67 and PCNA in non-small cell lung cancer: prognostic significance and comparison with p53 and bcl-2.细胞周期蛋白D1、Ki-67和增殖细胞核抗原在非小细胞肺癌中的表达:预后意义及与p53和bcl-2的比较
Acta Histochem. 2000 Aug;102(3):323-38. doi: 10.1078/s0065-1281(04)70039-2.
10
Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.细胞周期蛋白D1、E及细胞周期蛋白依赖性激酶抑制剂p21(Waf1/Cip1)和p27(Kip1)在尿路上皮癌中的表达模式:与其他细胞周期相关蛋白(Rb、p53、Ki-67和PCNA)及临床病理特征的相关性
Urol Int. 2004;73(1):65-73. doi: 10.1159/000078807.

引用本文的文献

1
The Molecular and Cellular Strategies of Glioblastoma and Non-Small-Cell Lung Cancer Cells Conferring Radioresistance.胶质母细胞瘤和非小细胞肺癌细胞的分子和细胞策略赋予其放射抵抗性。
Int J Mol Sci. 2022 Nov 5;23(21):13577. doi: 10.3390/ijms232113577.
2
Prognostic markers in lung cancer: is it ready for prime time?肺癌的预后标志物:是否已经准备好进入黄金时期?
Transl Lung Cancer Res. 2014 Jun;3(3):149-58. doi: 10.3978/j.issn.2218-6751.2014.06.09.
3
Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation.
非小细胞肺癌预后的免疫组化标志物:标志物评估多阶段方法的综述与建议
J Clin Pathol. 2006 Aug;59(8):790-800. doi: 10.1136/jcp.2005.031351.
4
Prognostic value of cyclin D1 overexpression in correlation with pRb and p53 status in non-small cell lung cancer (NSCLC).细胞周期蛋白D1过表达与非小细胞肺癌(NSCLC)中pRb和p53状态相关性的预后价值。
J Cancer Res Clin Oncol. 2005 Jul;131(7):479-85. doi: 10.1007/s00432-004-0661-9. Epub 2005 Apr 5.
5
Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer.细胞周期蛋白D1过表达是可切除非小细胞肺癌预后不良的一个指标。
Br J Cancer. 1999 Sep;81(1):127-32. doi: 10.1038/sj.bjc.6690661.
6
Cyclin D1 and human neoplasia.细胞周期蛋白D1与人类肿瘤
Mol Pathol. 1998 Feb;51(1):1-7. doi: 10.1136/mp.51.1.1.